(NASDAQ: HITI) High Tide's forecast annual revenue growth rate of 4.26% is forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of 3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.06%.
High Tide's revenue in 2024 is $497,661,000.On average, 3 Wall Street analysts forecast HITI's revenue for 2024 to be $30,438,589,669, with the lowest HITI revenue forecast at $30,363,960,252, and the highest HITI revenue forecast at $30,502,221,067. On average, 3 Wall Street analysts forecast HITI's revenue for 2025 to be $35,496,578,764, with the lowest HITI revenue forecast at $34,786,735,172, and the highest HITI revenue forecast at $36,495,356,034.
In 2026, HITI is forecast to generate $46,564,042,740 in revenue, with the lowest revenue forecast at $46,564,042,740 and the highest revenue forecast at $46,564,042,740.